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1. Introduction 
Structure-function studies performed to investigate 
the betacytotropic effect of arginine, have suggested 
that the guanidino group may be involved in triggering 
insulin release, since several compounds that contain 
this radical within their molecule are capable of 
stimulating the secretion of insulin, both in vivo [l] 
and in vitro [2] . 
Given that arginine also behaves as a potent 
glucagon secretagogue, whose mechanism of action 
remains unknown, we have examined the effect of 
guanidine and two guanidine derivatives (guanidino- 
acetic acid and creatine) on the secretory activity of 
the alpha-cell in a preparation of isolated mouse 
pancreatic islets. 
2. Methods and materials 
Four-week old Swiss male mice, fasted for 14 h, 
were used as pancreas donors. In each experiment a 
pool of 8 pancreases was employed. The islets were 
isolated by the collagenase technique [3] as modified 
by Coll-Garcia and Gill [4]. Batches of 10 islets were 
incubated for 60 min in 2 ml of a bicarbonate-buffered 
salt solution [S] (gas phase, 95:5, O2 t COa) contain- 
ing 0.2% bovine serum albumin (Cohn fraction IV), 
2000 U of kallikrein-trypsin inhibitor (Trasylol, 
Bayer) and 3.3 mM glucose (‘basal medium’). In order 
to verify the releasing activity of the islets, on each 
day arginine hydrochloride was used as a control 
secretagogue. All incubations were performed in a 
water bath at 37°C and at 60 strokes per min. At the 
end of the incubation, an aliquot of each sample was 
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diluted 1:4 in 0.2 M glycine containing 0.25% human 
albumin and 1% normal sheep serum (pH 8.8) and 
immediately frozen at -20°C until the time of 
analysis. Full details of this method will be published 
elsewhere [6]. 
Radioimmunoassay was used to estimate glucagon 
[7] and insulin [8]. The values were read against 
beef-pork glucagon (Eli Lilly) and mouse insulin 
(Novo) standards. Statistical differences were calcu- 
lated by unpaired t-test analysis. 
Collagenase was purchased from Boehringer 
Mannheim GmbH; arginine hydrochloride, guanidine 
HCl, guanidinoacetic acid and bovine serum albumin 
were obtained from Sigma Chem. Co. Glucagon 
antiserum (30K) was a generous gift from Dr R. H. 
Unger, Dallas. 
3. Results 
As expressed in table 1, glucagon release by mouse 
pancreatic islets incubated in the basal medium, was 
fairly constant in the three groups of experiments. 
The addition of 10 mM arginine induced, in all cases, 
a marked increase of glucagon output, the increments 
ranging from 140% to 410% of the basal values. 
When 10 mM guanidine was incorporated into the 
medium, glucagon release amounted to 110% above 
the basal value. Guanidinoacetic acid and creatin, both 
at 10 mM, were also effective stimuli of glucagon 
secretion, the increments being 50% and 140%, 
respectively. 
At the glucose concentration employed (3.3 mM), 
10 mM arginine elicited significant increments of 
insulin release, varying from 180% to 590%. While 
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Table 1 
Effect of arginine, guanidine, guanidinoacetic acid and creatine on glucagon and 
insulin release by incubated mouse pancreatic islets. These substances were used 
at 10 mM (means * SEM) 
Glucagon 
(pg/lO islets/60 min) 
Basal medium 
(N = 40) 309 ? 22 
Guanidine 
(N = 40) a654 ? lib 
Arginine 
(N = 40) 1571 f. 16gb 
Basal medium 
(N = 60) 321 f 14 
Guanidinoacetic acid 
(N = 84) a480 * 21b 
Arginine 
(N = 36) 166 f 39b 
Basal medium 
(N = 70) 200 t 10 
Creatine 
(N = 97) a479 + 70b 
Arginine 
(N = 42) 897 + 70b 
N = number of incubation vials. 
a P vs. basal value <O.OOOl. 
bPvs. arginine value <O.OOOOl. 
Insulin 
(ng/lO islets/60 min) 
1.4 f 0.15 
a1.5 f 0.2 
3.9 k 0.3b 
1.3 * 0.1 
a4.2 i- 0.2b 
9.0 f 0.7b 
1.3 k 0.1 
a3.6 r 0.2b 
7.6 + 0.9b 
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guanidinoacetic acid and creatine augmented the 
insulin-releasing activity of the islets (220% and 180%, 
respectively), no effect of guanidine on the secretion 
of this hormone was observed. 
4. Discussion 
Guanidine and the two guanidine derivatives tested, 
display a clear-cut glucagonotropic effect in the 
preparation of mouse pancreatic islets. Therefore, it 
seems reasonable to consider that the guanidino group 
may be in part responsible for the glucagon-releasing 
activity of arginine. 
Parenteral administration of arginine analogs, 
metabolizable and nonmetabolizable, has been previous- 
ly described to increase the levels of circulating 
glucagon in rats and dogs [9,10]. The fact that these 
compounds possess a guanidino residue, would support 
the concept that recognition of this radical by the 
alpha-cell may promote glucagon release. 
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